$AGNPF highlighted in MIT Technology Review Creating new drugs is a laborious process. It takes on average about 10 years to bring a new medicine to market, and even a rushed coronavirus vaccine is likely to take 12 to 18 months. Medicines that have already been tested in humans are already known not to be toxic; the only question is whether they work against covid-19 too. That means pharmaceutical companies can immediately put them into clinical trials. That’s what Algernon Pharmaceuticals, based in Vancouver, Canada, is doing, says CEO Christopher Moreau. Currently, they are investigating the potential of ifenprodil, a drug used to treat circulatory and neurological conditions. If successful, it could be mass distributed in eight to 10 months. https://www.technologyreview.com/2020/04/15/999481/repurposing-drugs-might-help-fight-coronavirus-pandemic/